Human CCR9/CC-CKR-9/ CDw199 ORF/cDNA clone-Lentivirus particle (NM_031200.2)

Pre-made Human CCR9/CC-CKR-9/ CDw199 Lentiviral expression plasmid for CCR9 lentivirus packaging, CCR9 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.

Target products collectionGo to CCR9/CC-CKR-9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)



Product information

Catalog No. Product Name lentivirus Grade lentivirus quantity
vGMLV000052 Human CCR9 Lentivirus particle Pilot Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
Research Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMLV000052
Gene Name CCR9
Accession Number NM_031200.2
Gene ID 10803
Species Human
Product Type Lentivirus particle (overexpression)
Insert Length 1110 bp
Gene Alias CC-CKR-9, CDw199, GPR-9-6, GPR28
Fluorescent Reporter
Mammalian Cell Selection Puromyocinmyocin
Fusion Tag Null
Promoter CMV
Resistance Amplicin

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-T97873-Ab Anti-CCR9/ CC-CKR-9/ CDw199 monoclonal antibody
    Target Antigen GM-Tg-g-T97873-Ag CCR9 VLP (virus-like particle)
    Cytokine cks-Tg-g-GM-T97873 chemokine (C-C motif) receptor 9 (CCR9) protein & antibody
    ORF Viral Vector pGMLV000052 Human CCR9 Lentivirus plasmid
    ORF Viral Vector vGMLV000052 Human CCR9 Lentivirus particle


    Target information

    Target ID GM-T97873
    Target Name CCR9
    Gene ID 10803, 12769, 713934, 282832, 101083247, 484793, 530951, 100065535
    Gene Symbol and Synonyms A130091K22Rik,CC-CKR-9,CCR9,CDw199,Cmkbr10,GPR-9-6,GPR28
    Uniprot Accession P51686
    Uniprot Entry Name CCR9_HUMAN
    Protein Sub-location Transmembrane Protein
    Category Therapeutics Target, Immuno-oncology Target, Cytokine Target
    Disease Not Available
    Gene Ensembl ENSG00000173585
    Target Classification Checkpoint-Immuno Oncology, GPCR

    The protein encoded by this gene is a G protein-coupled receptor with seven transmembrane domains that belongs to the beta chemokine receptor family. Chemokines and their receptors are key regulators of thymocyte migration and maturation in normal and inflammation conditions. This gene is differentially expressed in T lymphocytes of the small intestine and colon, and its interaction with chemokine 25 contributes to intestinal intra-epithelial lymphocyte homing to the small intestine. This suggests a role for this gene in directing immune responses to different segments of the gastrointestinal tract. This gene and its exclusive ligand, chemokine 25, are overexpressed in a variety of malignant tumors and are closely associated with tumor proliferation, apoptosis, invasion, migration and drug resistance. This gene maps to the chemokine receptor gene cluster. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020]



    About GMVC

    GDU



    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.